WARD Home
The project aims to enable patients’ rehabilitation in their own homes by ensuring early detection and intervention in case of disease deterioration. This is achieved through intelligent wireless monitoring, which can assess the patient’s condition 24/7 and alert hospital staff.
The proportion of citizens in Denmark with chronic diseases is increasing, which contributes to a rise in hospital admissions. This leads to a greater need for resources to monitor patients during hospitalization and a significant demand for discharges to their own homes or municipal rehabilitation facilities. The possibilities for monitoring and early intervention in case of disease deterioration are typically significantly reduced once the patient is discharged from the hospital, increasing the risk of readmission.
WARD Home builds on the CE-marked advanced clinical support system, WARD Clinical Support System, which has been developed with over 2500 hospitalized high-risk patients. The system consists of small wireless sensors that collect information about vital parameters (pulse, oxygen saturation, etc.). Clinically modeled algorithms, trained by experienced healthcare professionals, will then assess the patient’s condition and alert healthcare staff on their smartphones if needed, as well as address the current issue with false alarms for the staff.
Since 2022, WARD Home has expanded the solution so that the same sensors can be placed in the patient’s home and securely transmit data to the responsible healthcare professional (either from the discharging ward or the emergency services) through a VPN SIM card connection. WARD Home has so far been tested on over 200 patients and has completed technical scaling tests (ensuring the system can handle many simultaneous monitoring sessions without errors).

Study design:
Prospective observational study
Sample size:
120 Participants
Study Sites:
Bispebjerg Hospital, Rigshospitalet & Region Hovedstadens Akutberedskab
Inclusion criteria:
– Adult patients (≥18 years) admitted (with at least one night stay) with an acute medical or surgical disease and scheduled for discharge to their own homes
-Adult patients (≥18 years) who have contacted the EMS and, after assessment by paramedic personnel, not deemed sick enough for immediate hospital admission.
Study Procedures:
The study aims to investigate the use of wireless, continuous monitoring in patients at home including the frequency of alarms triggered by abnormal vital parameters and their significance for (re)hospitalisation/Serious
Adverse Events(SAE) and/or death within 30 days.
Outcome:
(re)hospitalisation/Serious Adverse Events(SAE) and/or death within 30 days.
Primary Investigators:
Emilie Sigvardt, MD
NCT:
NCT06077851